Jared Frisby, DO - Medicare Infectious Disease in Overland Park, KS

Jared Frisby, DO is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Overland Park, Kansas. He went to At Still University Of Health Sciences, College Of Osteo Med, Kirksville and graduated in 2017 and has 7 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Metro Infectious Disease Consultants Llc, Metro Infectious Disease Consultants Llc and his current practice location is 4601 W 109th St Ste 100, Overland Park, Kansas. You can reach out to his office (for appointments etc.) via phone at (913) 942-0540.

Jared Frisby is licensed to practice in Kansas (license number 05-46273) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1649706243.

Contact Information

Jared Frisby, DO
4601 W 109th St Ste 100,
Overland Park, KS 66211-1313
(913) 942-0540
(630) 528-9580



Physician's Profile

Full NameJared Frisby
GenderMale
SpecialityInfectious Disease
Experience7 Years
Location4601 W 109th St Ste 100, Overland Park, Kansas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jared Frisby attended and graduated from At Still University Of Health Sciences, College Of Osteo Med, Kirksville in 2017
  NPI Data:
  • NPI Number: 1649706243
  • Provider Enumeration Date: 05/03/2017
  • Last Update Date: 07/08/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 2961827589
  • Enrollment ID: I20220716000158

Medical Identifiers

Medical identifiers for Jared Frisby such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1649706243NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease 05-46273 (Kansas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Lee's Summit Medical CenterLees summit, MOHospital
Saint Luke's East HospitalLees summit, MOHospital
Research Medical CenterKansas city, MOHospital
Overland Park Reg Med CtrOverland park, KSHospital
Saint Luke's South HospitalOverland park, KSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Metro Infectious Disease Consultants Llc3072425784297
Metro Infectious Disease Consultants Llc3072425784297

News Archive

Strand, Trovagene enter MOU to license and validate HPV assay technology

Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Disparities in breast cancer mortality continues to be high in Chicago: Data

Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

Uptake Medical completes Series B financing led by Maverick Capital

Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jared Frisby allows following entities to bill medicare on his behalf.
Entity NameMetro Infectious Disease Consultants Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235125717
PECOS PAC ID: 3072425784
Enrollment ID: O20170712003292

News Archive

Strand, Trovagene enter MOU to license and validate HPV assay technology

Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Disparities in breast cancer mortality continues to be high in Chicago: Data

Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

Uptake Medical completes Series B financing led by Maverick Capital

Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jared Frisby is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jared Frisby, DO
901 Mcclintock Dr Ste 202,
Burr Ridge, IL 60527-0872

Ph: (630) 655-8320
Jared Frisby, DO
4601 W 109th St Ste 100,
Overland Park, KS 66211-1313

Ph: (913) 942-0540

News Archive

Strand, Trovagene enter MOU to license and validate HPV assay technology

Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Disparities in breast cancer mortality continues to be high in Chicago: Data

Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

Uptake Medical completes Series B financing led by Maverick Capital

Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Overland Park, KS

Dr. Matthew P Harrison, MD
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 10116 W 105th St, Overland Park, KS 66212
Phone: 913-541-0510    Fax: 913-541-1852
Louay K. Sabih, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 10550 Marty St Ste 201, Overland Park, KS 66212
Phone: 913-341-4000    Fax: 913-383-2868
Kimberly Foley Nagel, ARNP
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 5701 W 119th St, Suite 345, Overland Park, KS 66209
Phone: 913-339-9046    Fax: 913-339-9018
Dr. Paul G Diederich, M.D.
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 10787 Nall Ave, Ste. 310, Overland Park, KS 66211
Phone: 913-945-6900    Fax: 913-945-6970
Mini R Abraham, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 10000 College Blvd, Overland Park, KS 66210
Phone: 913-258-5055    Fax: 913-258-5057
Jeena Viji Eapen, M.D.
Infectious Disease
Medicare: May Accept Medicare Assignments
Practice Location: 10540 Marty St Ste 100, Overland Park, KS 66212
Phone: 913-660-1616    Fax: 913-660-0998
Dr. Arnold Leslie Katz, MD
Infectious Disease
Medicare: May Accept Medicare Assignments
Practice Location: 10550 Quivira Road, Suite 320, Overland Park, KS 66215
Phone: 913-888-3231    Fax: 913-888-7281

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.